Cite
Kelly DJ, McCann GP, Blackman D, et al. Complete Versus culprit-Lesion only PRimary PCI Trial (CVLPRIT): a multicentre trial testing management strategies when multivessel disease is detected at the time of primary PCI: rationale and design. EuroIntervention. 2013;8(10):1190-8doi: 10.4244/EIJV8I10A183.
Kelly, D. J., McCann, G. P., Blackman, D., Curzen, N. P., Dalby, M., Greenwood, J. P., Fairbrother, K., Shipley, L., Kelion, A., Heatherington, S., Khan, J. N., Nazir, S., Alahmar, A., Flather, M., Swanton, H., Schofield, P., Gunning, M., Hall, R., & Gershlick, A. H. (2013). Complete Versus culprit-Lesion only PRimary PCI Trial (CVLPRIT): a multicentre trial testing management strategies when multivessel disease is detected at the time of primary PCI: rationale and design. EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 8(10), 1190-8. https://doi.org/10.4244/EIJV8I10A183
Kelly, Damian J, et al. "Complete Versus culprit-Lesion only PRimary PCI Trial (CVLPRIT): a multicentre trial testing management strategies when multivessel disease is detected at the time of primary PCI: rationale and design." EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology vol. 8,10 (2013): 1190-8. doi: https://doi.org/10.4244/EIJV8I10A183
Kelly DJ, McCann GP, Blackman D, Curzen NP, Dalby M, Greenwood JP, Fairbrother K, Shipley L, Kelion A, Heatherington S, Khan JN, Nazir S, Alahmar A, Flather M, Swanton H, Schofield P, Gunning M, Hall R, Gershlick AH. Complete Versus culprit-Lesion only PRimary PCI Trial (CVLPRIT): a multicentre trial testing management strategies when multivessel disease is detected at the time of primary PCI: rationale and design. EuroIntervention. 2013 Feb 22;8(10):1190-8. doi: 10.4244/EIJV8I10A183. PMID: 23425543.
Copy
Download .nbib